About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 2344 record(s)
Req # A-2021-000420
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075019-732.Organization: Health Canada
December 2021
Req # A-2021-000475
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114293-165, Amendments to the Patented Medicines Regulations.Organization: Health Canada
December 2021
Req # A-2021-000479
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116936-246.Organization: Health Canada
December 2021
Req # A-2021-000506
Adverse Drug Reaction (ADR) TERIFLUNOMIDE. Report number: E2B_03519847.Organization: Health Canada
December 2021
Req # A-2021-000535
Adverse Drug Reactions (ADRs) for CLOPIDOGREL BISULFATE. Report numbers: E2B_03388107, E2B_03388434.Organization: Health Canada
December 2021
Req # A-2021-000557
Adverse Drug Reactions (ADRs) for TRIAMCINOLONE ACETONIDE. Report numbers: E2B_03413307, E2B_03432341, E2B_03310509, E2B_03518327.Organization: Health Canada
December 2021
Req # A-2021-000564
Adverse Drug Reactions (ADRs) for ACEBUTOLOL HYDROCHLORIDE. Report numbers: 000929730, E2B_03505032, E2B_03371322, E2B_03498962, E2B_03501946, E2B_03482477.Organization: Health Canada
December 2021
Req # A-2021-000566
Adverse Drug Reaction (ADR) for INSULIN GLARGINE. Report number: 000927197.Organization: Health Canada
December 2021
Req # A-2021-000579
Adverse Drug Reactions (ADRs). Report numbers: E2B_03907596, E2B_03907601, E2B_03907608, E2B_03912380, E2B_03912400, E2B_03912503, E2B_03848354, E2B_03885413, E2B_03885517, E2B_03903766, E2B_03909452, E2B_03950354, E2B_03950783.Organization: Health Canada
December 2021
Req # A-2021-000656
Adverse Drug Reactions (ADRs) for Diclectin (doxylamine succinate / pyridoxine hydrochloride). Report numbers: 000640670, 000670872, 000122947.Organization: Health Canada
December 2021